Grantable
Clinical Updates and Strategies in the Treatment and Management of First-line BRAF V600E-mutant Metastatic Colorectal Cancer Grant · THE PFIZER FOUNDATION INC
up to $500,000
Clinical Updates and Strategies in the Treatment and Management of First-line BRAF V600E-mutant Metastatic Colorectal Cancer Grant Status: ACTIVE Funder: Pfizer, Inc. Amount: Up to US $500,000 Last Updated: June 11, 2025 Summary Pfizer is offering a competitiv…
Welcome to Grantable
Sign in to start building your grant-ready profile
or
We'll send you a one-time verification code. No password needed. By signing in you agree to our Terms of Service and Privacy Policy.